186 related articles for article (PubMed ID: 8605007)
1. Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane.
Bambal RB; Hanzlik RP
Biochem Biophys Res Commun; 1996 Feb; 219(2):445-9. PubMed ID: 8605007
[TBL] [Abstract][Full Text] [Related]
2. Effects of steric bulk and conformational rigidity on fatty acid omega hydroxylation by a cytochrome P450 4A1 fusion protein.
Bambal RB; Hanzlik RP
Arch Biochem Biophys; 1996 Oct; 334(1):59-66. PubMed ID: 8837739
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
[TBL] [Abstract][Full Text] [Related]
4. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
[TBL] [Abstract][Full Text] [Related]
5. Heme-coordinating analogs of lauric acid as inhibitors of fatty acid omega-hydroxylation.
Lu P; Alterman MA; Chaurasia CS; Bambal RB; Hanzlik RP
Arch Biochem Biophys; 1997 Jan; 337(1):1-7. PubMed ID: 8990261
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid discrimination and omega-hydroxylation by cytochrome P450 4A1 and a cytochrome P4504A1/NADPH-P450 reductase fusion protein.
Alterman MA; Chaurasia CS; Lu P; Hardwick JP; Hanzlik RP
Arch Biochem Biophys; 1995 Jul; 320(2):289-96. PubMed ID: 7625836
[TBL] [Abstract][Full Text] [Related]
7. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
8. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
Loughran PA; Roman LJ; Miller RT; Masters BS
Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
[TBL] [Abstract][Full Text] [Related]
9. The omega-hydroxlyation of lauric acid: oxidation of 12-hydroxlauric acid to dodecanedioic acid by a purified recombinant fusion protein containing P450 4A1 and NADPH-P450 reductase.
Shet Ms; Fisher CW; Holmans PL; Estabrook RW
Arch Biochem Biophys; 1996 Jun; 330(1):199-208. PubMed ID: 8651697
[TBL] [Abstract][Full Text] [Related]
10. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
Murataliev MB; Feyereisen R
Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
[TBL] [Abstract][Full Text] [Related]
11. Drosophila melanogaster CYP6A8, an insect P450 that catalyzes lauric acid (omega-1)-hydroxylation.
Helvig C; Tijet N; Feyereisen R; Walker FA; Restifo LL
Biochem Biophys Res Commun; 2004 Dec; 325(4):1495-502. PubMed ID: 15555597
[TBL] [Abstract][Full Text] [Related]
12. Omega- and (omega-1)-hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450.
Imaoka S; Tanaka S; Funae Y
Biochem Int; 1989 Apr; 18(4):731-40. PubMed ID: 2504167
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4.
Scheller U; Zimmer T; Kärgel E; Schunck WH
Arch Biochem Biophys; 1996 Apr; 328(2):245-54. PubMed ID: 8645001
[TBL] [Abstract][Full Text] [Related]
14. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.
Powell PK; Wolf I; Lasker JM
Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854
[TBL] [Abstract][Full Text] [Related]
15. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.
Lüdemann SK; Lounnas V; Wade RC
J Mol Biol; 2000 Nov; 303(5):797-811. PubMed ID: 11061976
[TBL] [Abstract][Full Text] [Related]
16. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling and substrate binding study of human CYP4A11 enzyme.
Chang YT; Loew GH
Proteins; 1999 Feb; 34(3):403-15. PubMed ID: 10024026
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
19. Heteroatom substitution shifts regioselectivity of lauric acid metabolism from omega-hydroxylation to (omega-1)-oxidation.
Alterman MA; Chaurasia CS; Lu P; Hanzlik RP
Biochem Biophys Res Commun; 1995 Sep; 214(3):1089-94. PubMed ID: 7575514
[TBL] [Abstract][Full Text] [Related]
20. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases.
Hoch U; Zhang Z; Kroetz DL; Ortiz de Montellano PR
Arch Biochem Biophys; 2000 Jan; 373(1):63-71. PubMed ID: 10620324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]